The stock has been rated “underperform.” Analysts from the Jefferies Group have said to “hold” on purchasing the company’s stock, while JPMorgan Chase gave it a “neutral” rating.
Victrex works with manufacturing of high performance polymers through its two business units, Invibio Biomaterial Solutions and Victrex Polymer Solutions.
More Articles on Devices:
MAKO Surgical Settles Lawsuit, Acquires Stanmore Robotic Assets
Stryker Releases Spine Screw, Surgical Devices
Sonoma Orthopedic Products Develops Minimally Invasive Technique For Fractures
